| Nahrain H Alzubaidi, MD | |
|
4211 Fairfax Corner East Ave, Suite 230, Fairfax, VA 22030-8622 | |
| (703) 802-9600 | |
| (703) 802-9602 |
| Full Name | Nahrain H Alzubaidi |
|---|---|
| Gender | Female |
| Speciality | Endocrinology |
| Experience | 35 Years |
| Location | 4211 Fairfax Corner East Ave, Fairfax, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447258538 | NPI | - | NPPES |
| 5878845 | Medicaid | VA | |
| 034310100 | Medicaid | DC | |
| 460003745 | Other | MEDICARE RAILROAD | |
| 400157500 | Medicaid | MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 33897 (District Of Columbia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Novant Health Uva Health Haymarket Medical Center | Haymarket, VA | Hospital |
| Inova Fairfax Hospital | Falls church, VA | Hospital |
| Inova Fair Oaks Hospital | Fairfax, VA | Hospital |
| Entity Name | Virginia Diabetes,obesity And Endocrinology Center, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437353604 PECOS PAC ID: 6305862533 Enrollment ID: O20051018000308 |
News Archive
In some states, the task of helping consumers find their way through the health law's new online insurance marketplace has fallen to "navigators." In general, though, news outlets report on the strategies and public outreach efforts underway in locations across the country.
Syndax Pharmaceuticals, a clinical-stage epigenetics oncology company, today announced allowance by the European Patent Office for the patent application titled "N-(2-AMINOPHENYL)-4[N-(PYRIDINE-3-YL) - METHOXYCARBONYL - AMINOMETHYL]-BENZAMINE (MS-275) POLYMORPH B."
A team of investigators at The Scripps Research Institute and the Genomics Institute of the Novartis Research Foundation (GNF) have discovered a way to screen hundreds and potentially thousands of "noncoding" RNA molecules to discover their functions within cells.
InVivo Therapeutics a company focused on the development of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today announced that it has been awarded $244,000 in grant funding as part of the U.S. Government's Qualifying Therapeutic Discovery Project (QTDP) program.
Sleep-related deaths are the most common cause of death for infants 1-12 months of age. The American Academy of Pediatrics recommends that infants sleep on their back on a firm mattress, without loose bedding. However, many parents use sitting or carrying devices, such as car seats, swings, or bouncers, as alternative sleeping environments, which could lead to potential injury or death.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nahrain H Alzubaidi, MD 4211 Fairfax Corner East Ave, Suite 230, Fairfax, VA 22030-8623 Ph: (703) 802-9600 | Nahrain H Alzubaidi, MD 4211 Fairfax Corner East Ave, Suite 230, Fairfax, VA 22030-8622 Ph: (703) 802-9600 |
News Archive
In some states, the task of helping consumers find their way through the health law's new online insurance marketplace has fallen to "navigators." In general, though, news outlets report on the strategies and public outreach efforts underway in locations across the country.
Syndax Pharmaceuticals, a clinical-stage epigenetics oncology company, today announced allowance by the European Patent Office for the patent application titled "N-(2-AMINOPHENYL)-4[N-(PYRIDINE-3-YL) - METHOXYCARBONYL - AMINOMETHYL]-BENZAMINE (MS-275) POLYMORPH B."
A team of investigators at The Scripps Research Institute and the Genomics Institute of the Novartis Research Foundation (GNF) have discovered a way to screen hundreds and potentially thousands of "noncoding" RNA molecules to discover their functions within cells.
InVivo Therapeutics a company focused on the development of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today announced that it has been awarded $244,000 in grant funding as part of the U.S. Government's Qualifying Therapeutic Discovery Project (QTDP) program.
Sleep-related deaths are the most common cause of death for infants 1-12 months of age. The American Academy of Pediatrics recommends that infants sleep on their back on a firm mattress, without loose bedding. However, many parents use sitting or carrying devices, such as car seats, swings, or bouncers, as alternative sleeping environments, which could lead to potential injury or death.
› Verified 1 days ago
Shivangi Vachhani, M.D. Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 3700 Joseph Siewick Dr Ste 408a, Fairfax, VA 22033 Phone: 877-511-4625 Fax: 703-204-9006 | |
Dr. Raymund S Cuevo, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 8081 Innovation Park Dr, Fairfax, VA 22031 Phone: 571-472-4724 Fax: 571-472-0241 | |
Dr. Michael Maitland, M.D., PH.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 8081 Innovation Park Dr, Fairfax, VA 22031 Phone: 571-472-4724 Fax: 571-472-1601 | |
Dr. Paul G. Rochmis, M.D. Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 3027 Javier Rd, Suite 2, Fairfax, VA 22031 Phone: 703-573-2220 Fax: 703-573-7767 | |
Aswani Kumar Suthrave, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 3600 Joseph Siewick Dr, Fairfax, VA 22033 Phone: 703-391-3600 | |
Nader H Balba, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 3028 Javier Rd Ste 500, Fairfax, VA 22031 Phone: 703-698-8960 Fax: 571-494-5794 | |
Rona Harthill Earle, Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 3020 Hamaker Ct Ste B102, Fairfax, VA 22031 Phone: 703-573-4072 Fax: 703-572-2153 |